Dr. Chatterjee was a Licensing and Patenting Associate at OTT before joining the Cancer Branch as a Licensing and Patenting Manager. Prior to that Dr. Chatterjee he has worked as a Technical Specialist in the Biotechnology/Chemical Group at a Washington D.C. IP law firm and a Senior Technology Transfer Fellow at OTT. Dr. Chatterjee is a co-founder of a start-up company that provides information technology and statistical solutions for the healthcare industry. He received his post-doctoral research training from Harvard Medical School, Children’s Hospital, Boston, where he studied the mechanism of drug resistance. Dr. Chatterjee received his PhD in Biological Chemistry from the State University of New York at Binghamton and his MBA from the Isenberg School of Business at the University of Massachusetts-Amherst.